Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × sargramostim × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

venetoclax 27 Azacitidine 25 fludarabine 22 Cyclophosphamide 15 fludarabine phosphate 14 Decitabine 13 Specimen Handling 12 Cytarabine 12 Whole-Body Irradiation 11 Busulfan 11 Biopsy 11 Stem Cell Transplantation 10 Tacrolimus 9 Mycophenolic Acid 9 decitabine and cedazuridine drug combination 8 Granulocyte Colony-Stimulating Factor 8 Methotrexate 7 Melphalan 7 Injections 7 Thiotepa 6 Peripheral Blood Stem Cell Transplantation 5 Idarubicin 5 Filgrastim 5 Daunorubicin 5 Blood Specimen Collection 5 Mesna 4 Cyclosporine 4 Cladribine 4 thymoglobulin 3 olutasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡